AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
Log in

NYSE:TFXTeleflex Stock Price, Forecast & News

$358.29
+10.66 (+3.07 %)
(As of 05/28/2020 04:00 PM ET)
Add
Compare
Today's Range
$349.01
Now: $358.29
$359.34
50-Day Range
$308.39
MA: $339.19
$363.24
52-Week Range
$221.27
Now: $358.29
$398.65
Volume315,800 shs
Average Volume281,400 shs
Market Capitalization$16.63 billion
P/E Ratio30.65
Dividend Yield0.39%
Beta0.99
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Read More
Teleflex logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.2Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.06 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP87936910
Phone610-225-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.60 billion
Cash Flow$16.44 per share
Book Value$66.19 per share

Profitability

Net Income$461.47 million

Miscellaneous

Employees14,400
Market Cap$16.63 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

Teleflex (NYSE:TFX) Frequently Asked Questions

How has Teleflex's stock been impacted by COVID-19 (Coronavirus)?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TFX shares have increased by 4.7% and is now trading at $358.29. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Teleflex?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Teleflex.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Teleflex.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings data on Thursday, April, 30th. The medical technology company reported $2.72 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.30 by $0.42. The medical technology company had revenue of $630.60 million for the quarter, compared to analysts' expectations of $609.07 million. Teleflex had a net margin of 21.12% and a return on equity of 18.96%. The firm's revenue for the quarter was up 2.8% on a year-over-year basis. During the same period in the previous year, the firm earned $2.24 earnings per share. View Teleflex's earnings history.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Tuesday, May 5th. Shareholders of record on Friday, May 15th will be given a dividend of $0.34 per share on Monday, June 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date is Thursday, May 14th. View Teleflex's dividend history.

What price target have analysts set for TFX?

10 equities research analysts have issued twelve-month target prices for Teleflex's stock. Their forecasts range from $275.00 to $431.00. On average, they expect Teleflex's stock price to reach $381.40 in the next twelve months. This suggests a possible upside of 6.5% from the stock's current price. View analysts' price targets for Teleflex.

Has Teleflex been receiving favorable news coverage?

News stories about TFX stock have trended very negative on Thursday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Teleflex earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned headlines about the medical technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutTeleflex.

Who are some of Teleflex's key competitors?

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include Alibaba Group (BABA), NVIDIA (NVDA), AbbVie (ABBV), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Vertex Pharmaceuticals (VRTX), Visa (V), Adobe (ADBE), salesforce.com (CRM) and Pfizer (PFE).

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Mr. Liam J. Kelly, Pres, CEO & Director (Age 52)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 57)
  • Mr. James J. Leyden, VP, Gen. Counsel & Sec. (Age 52)
  • Mr. John R. Deren, VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy, Chief Information Officer & VP

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.03%), Atlanta Capital Management Co. L L C (4.31%), State Street Corp (4.13%), Wellington Management Group LLP (2.65%), Invesco Ltd. (2.27%) and Janus Henderson Group PLC (1.75%). Company insiders that own Teleflex stock include Andrew A Krakauer, Benson Smith, Cameron P Hicks, James J Leyden, John C Heinmiller, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle, Thomas Anthony Kennedy and Thomas E Powell. View institutional ownership trends for Teleflex.

Which major investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including Atlanta Capital Management Co. L L C, Scout Investments Inc., Wellington Management Group LLP, Lord Abbett & CO. LLC, Invesco Ltd., Janus Henderson Group PLC, Principal Financial Group Inc., and Carillon Tower Advisers Inc.. Company insiders that have sold Teleflex company stock in the last year include Benson Smith, Cameron P Hicks, James J Leyden, John Deren, Karen Boylan, Stephen K MD Klasko, and Thomas E Powell. View insider buying and selling activity for Teleflex.

Which major investors are buying Teleflex stock?

TFX stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Bessemer Group Inc., The Manufacturers Life Insurance Company , Bank of New York Mellon Corp, Swiss National Bank, Ensign Peak Advisors Inc, Conestoga Capital Advisors LLC, and William Blair Investment Management LLC. Company insiders that have bought Teleflex stock in the last two years include Andrew A Krakauer, and John C Heinmiller. View insider buying and selling activity for Teleflex.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $358.29.

How big of a company is Teleflex?

Teleflex has a market capitalization of $16.63 billion and generates $2.60 billion in revenue each year. The medical technology company earns $461.47 million in net income (profit) each year or $11.15 on an earnings per share basis. Teleflex employs 14,400 workers across the globe.

What is Teleflex's official website?

The official website for Teleflex is www.teleflex.com.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]

This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.